Geojit maintains hold on Cadila Healthcare, target price Rs 270
The stock closed Rs 259, up 1.6 per cent on Thursday.
Last Updated: Nov 29, 2019, 12.16 PM IST
Geojit has maintained its hold rating on Cadila Healthcare with a target price of Rs 270. During the quarter ending September, gross margin expanded 167 basis point on account of growth in Indian and US business. The brokerage said margin expansion remains contingent on recovery in domestic generic business and new US launches. The stock closed Rs 259, up 1.6 per cent on Thursday.
Commenting feature is disabled in your country/region.